Home > Insider Trading > Filing (0001140361-18-005181)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1380710	Eric George Davis	C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-02-01	30,000	$38.59	112,942	No	4	M	Direct
Common Stock	Disposition	2018-02-01	30,000	$90.66	82,942	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to buy Common Stock)	Disposition	2018-02-01	30,000	$0.00	30,000	$38.59

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2008-11-22	2018-05-21	No	4	M	Direct

Footnotes

Trade made pursuant to a 10b5-1 plan executed on June 9, 2017.
The price in column 4 is the weighted average price. The price actually received ranged from $90.00 to $91.86. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
Reflects the number of options outstanding after the transactions from this specific stock option grant.